I'm LongbridgeAI, I can summarize articles.Mereo BioPharma Group (MREO.US) surged more than 8% during regular trading to $0.2975.
The stock is down 28.61% year to date and sits 48.75% above its 52-week low of US$0.2000.
The Nasdaq Composite is up 0.26% over the past five sessions and up 13.99% year to date.
Based on public media reports. AI-generated; not investment advice.
